RSV Vaccines Based on Risk
RSV Vaccines in Adults: A Risk-Based Approach

Released: December 27, 2023

Angela Branche
Angela Branche, MD, FIDSA

Activity

Progress
1
Course Completed

In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including:

  • Current Advisory Committee on Immunization Practices recommendations
  • Risk factors associated with severe RSV disease, including RSV-related hospitalizations
  • Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine
  • Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities
  • Health disparities related to RSV vaccines
  • Considerations for a risk-based approach, rather than age alone, to determine vaccine candidacy